Mesa Maria D, Olza Josune, Gonzalez-Anton Carolina, Aguilera Concepcion M, Moreno-Torres Rosario, Jimenez Africa, Perez de la Cruz Antonio, Ruperez Azahara I, Gil Angel
Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology "Jose Mataix", Biomedical Research Centre, Health Science Technological Park, University of Granada, Avenida del Conocimiento s/n, 18016 Granada, Spain.
Clinical Nutrition and Dietetic Unit, University Hospital Virgen de las Nieves, Avenida de las Fuerzas Armadas 2, 18014 Granada, Spain.
Oxid Med Cell Longev. 2015;2015:5709312. doi: 10.1155/2016/5709312. Epub 2015 Dec 1.
We aim to evaluate whether exclusive feeding of an enteral formula enriched with n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA) affects oxidative stress and the antioxidant defence system and may improve the levels of some relevant inflammatory, and cardiovascular biomarkers in frail adults over fifty years of age and in elderly subjects. Fifty-five patients were divided into two groups and were exclusively fed a newly designed normoproteic and isocaloric enteral formula enriched with eicosapentaenoic (98 mg/d) and docosahexaenoic acids (46 mg/d) (n = 26) or a reference enteral diet (n = 29). Oxidative, inflammatory and cardiovascular risk biomarkers and red blood cell fatty acid profiles were determined at the beginning and after 90 and 180 days of feeding. The n-3 LC-PUFA percentage tended to be higher (P = 0.053) in the experimental group than in the reference group. Administration of the n-3 LC-PUFA diet did not increase oxidative stress or modify plasma antioxidant capacity but decreased antioxidant enzymatic activities. MMP-9 plasma concentration decreased with both formulae, whereas tPAI-1 tended to decrease (P = 0.116) with the administration of the experimental formula. In conclusion, administration of the new n-3 LC-PUFA-enriched product for 6 months did not negatively alter the oxidative status and improved some cardiovascular risk biomarkers.
我们旨在评估单纯喂食富含n-3长链多不饱和脂肪酸(n-3 LC-PUFA)的肠内配方奶粉是否会影响氧化应激和抗氧化防御系统,并可能改善50岁以上体弱成年人及老年受试者体内一些相关炎症和心血管生物标志物的水平。55名患者被分为两组,分别单纯喂食一种新设计的富含二十碳五烯酸(98毫克/天)和二十二碳六烯酸(46毫克/天)的正常蛋白质和等热量肠内配方奶粉(n = 26)或一种对照肠内饮食(n = 29)。在喂食开始时以及90天和180天后测定氧化、炎症和心血管风险生物标志物以及红细胞脂肪酸谱。实验组的n-3 LC-PUFA百分比有高于对照组的趋势(P = 0.053)。喂食n-3 LC-PUFA饮食并未增加氧化应激或改变血浆抗氧化能力,但降低了抗氧化酶活性。两种配方奶粉都使血浆MMP-9浓度降低,而喂食实验组配方奶粉时tPAI-1有降低趋势(P = 0.116)。总之,喂食新的富含n-3 LC-PUFA的产品6个月并未对氧化状态产生负面影响,且改善了一些心血管风险生物标志物。